Winton Group LTD Sarepta Therapeutics, Inc. Transaction History

Winton Group LTD

$1.31 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$113.33 - $163.85 $304,631 - $440,428	2,688 New	2,688 $424,000
Q2 2023 Aug 14, 2023	SELL	$106.4 - $157.19 $355,588 - $525,328	-3,342 Reduced 54.21%	2,823 $323,000
Q1 2023 May 12, 2023	SELL	$117.53 - $155.99 $791,211 - $1.05 Million	-6,732 Reduced 52.2%	6,165 $849,000
Q4 2022 Feb 14, 2023	BUY	$100.86 - $132.13 $1.3 Million - $1.7 Million	12,897 New	12,897 $1.67 Million
Q1 2022 May 11, 2022	SELL	$63.15 - $90.42 $658,654 - $943,080	-10,430 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$77.28 - $99.42 $806,030 - $1.04 Million	10,430 New	10,430 $939,000
Q2 2021 Aug 10, 2021	SELL	$69.38 - $86.75 $323,588 - $404,602	-4,664 Closed	0 $0
Q1 2021 Jul 21, 2021	SELL	$72.25 - $168.95 $61,195 - $143,100	-847 Reduced 15.37%	4,664 $348,000
Q4 2020 Feb 12, 2021	SELL	$125.56 - $178.74 $3.5 Million - $4.99 Million	-27,895 Reduced 83.5%	5,511 $940,000
Q3 2020 Oct 30, 2020	SELL	$127.12 - $172.34 $994,714 - $1.35 Million	-7,825 Reduced 18.98%	33,406 $4.69 Million
Q2 2020 Aug 05, 2020	BUY	$93.0 - $171.7 $456,537 - $842,875	4,909 Added 13.52%	41,231 $6.61 Million
Q1 2020 May 11, 2020	BUY	$82.38 - $131.64 $1.4 Million - $2.24 Million	17,036 Added 88.33%	36,322 $3.55 Million
Q4 2019 Feb 13, 2020	BUY	$76.53 - $135.58 $701,167 - $1.24 Million	9,162 Added 90.5%	19,286 $2.49 Million
Q3 2019 Nov 08, 2019	BUY	$72.81 - $156.91 $404,241 - $871,164	5,552 Added 121.43%	10,124 $763,000
Q2 2019 Jul 08, 2019	SELL	$112.21 - $151.95 $336,517 - $455,698	-2,999 Reduced 39.61%	4,572 $695,000
Q1 2019 May 13, 2019	SELL	$106.67 - $151.68 $298,889 - $425,007	-2,802 Reduced 27.01%	7,571 $902,000
Q4 2018 Feb 05, 2019	BUY	$97.32 - $148.76 $445,530 - $681,023	4,578 Added 79.0%	10,373 $1.13 Million
Q3 2018 Nov 02, 2018	SELL	$115.31 - $161.51 $49,698 - $69,610	-431 Reduced 6.92%	5,795 $0
Q2 2018 Aug 20, 2018	SELL	$71.74 - $153.69 $341,841 - $732,332	-4,765 Reduced 43.35%	6,226 $0
Q1 2018 May 21, 2018	BUY	$54.02 - $82.27 $593,733 - $904,229	10,991 New	10,991 $0

Others Institutions Holding SRPT

# of Institutions

525

Shares Held

84.4M

Call Options Held

2.06M

Put Options Held

1.52M

Black Rock Inc. New York, NY

10.3M
Shares

$1.17 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

8.97M
Shares

$1.02 Billion
0.02% of portfolio
Capital International Investors Los Angeles, CA

6.26M
Shares

$712 Million
0.16% of portfolio
Janus Henderson Group PLC London, X0

4.36M
Shares

$496 Million
0.29% of portfolio
State Street Corp Boston, MA

4.27M
Shares

$486 Million
0.02% of portfolio

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.96B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.

Account